I'm thinking when are they going to put that hand out for more money. Then they know us. I love how some of the longs immediately started drinking the kool-aide. Before I give them another dime, they need to show us something. They will keep this price above .37 so the .30 looks like we are getting a deal. I say under subscribe to the deal this time. make LB pay up, maybe that will motivate them to get a buyer in here and hopefully we get half our money back.
The info is limited until they have the deal done. Then they can open up on plans. Look Frost owns 25% of BZNE and a big piece of Cocrystals. Would he marry these two together if it didn't make sense? He could have found a shell anywhere, do a reverse split and bring Cocrystals out on it's own.
Devil is in the details. Insiders are buying up Muscle. They have Walgreens on board and I bet we see that stock move first, meaning our deal is stronger. If they spike to $20, our deal doubles. Small float on Muscle. Would not take much to get that to pop. 7000 pharmacies selling the muscle product.
Goldilocks think's that the porridge is too hot. I actually love how she's trading. Now in a range and any weakness is met with buyers. We don't have all the news yet, do we? We could soon partner anyone of these compounds out shortly after going public. They could have $50M in cash and equivalents soon. They will structure this where it makes sense to all investors. What good does it do Dr. Frost if this tanks.
Every board has a goldilocks. He's jealous and missed this opportunity. Most likely panic at .16 and sold his shares. Has he posted anything reliable...nope. Cocrystals needed a shell, they are willing to give up 40% of their efforts...meaning they expect to make that up. Something tells me you give up 40% to make maybe 1000%,2000%,10,000%. Plus they get 1.2M shares of Muscle to boot and the Qusomes benefits. Goldilocks thinks he can drive this down, he miscalculated. He knows it and we longs know it.
Doesn't Teva have to pony up the $38M still? They don't get 23% without it. Add that to the $12M BZNE already has, looks like they have funds for ph1/2 and some of the ph3. This is not like cancer, plenty of patients to try this drug. Hopefully they are far enough a long to get it in trial in 1H14.
I believe what we may see is a surprise on the assets that went to muscle. Those shares could pop and add some value to the 1.2M that BZNE enjoys. Now would BZNE still enjoy the rewards from OPK plans to use the delivery method? That agreement is with BZNE and OPK right?
I noticed the 13 TX store opens on Friday. The Houston store could be opening soon also. That should give them a good start to 1Q14. Adds about $450K in revenues. Having 14 stores compared to the 10 or 11 that operated this past quarter.
The article talks about this January the first 50 IPO's. Keeping my fingers crossed that this includes the PVA. Who did Clayton talk into lending them $32K? He had to give them a good reason.
We sure would like to see that 5M shares on the balance sheet.
50 IPO in china set for January! Is the PVA one of them? Here is article:
Regulatory review of 760 companies under way as China prepares to relaunch IPO market
About 50 Chinese companies will launch, or be ready to launch, an IPO by the end of January 2014, according to the China Securities Regulatory Commission (CSRC).
A further 760 companies are awaiting permission from regulators to launch IPOs and a review of these requests will take about a year, the regulator announced at the weekend, further raising expectations of an imminent resumption of Chinese IPOs.
The government is preparing to release new rules for its IPO market, which has been essentially frozen since November 2012 as regulators seek to adopt a ‘regulatory-based’ system instead of the current ‘approval-based’ system that has dramatically slowed issuance.
Under the approval-based system, the CSRC has exclusive powers to authorize a company to carry out an IPO. The process can take years and involve multiple interviews in which regulators seek to determine whether the company can sustain profitability. Under the regulatory-based system, companies would have to undergo legal and financial checks, but would be free to choose the timing and size of their IPOs.
Google MPRP/Hawkeye and willbros. They had a contract where the utility company was to supply things and they screwed around costing Hawkeye/Willbros about $43M in extra costs. I feel that they will get a settlement around $37M.
Sentiment: Strong Buy
Show us some examples or keep playing pocket pool. You make a claim here and show nothing to support it.
Nice article. WG turn around and targets $14 near term. We could get some interest here. I wish they would have touched on the modular LNG story a little. This could push it above $10 and keep her there this time.
We could soon see a settlement in the lawsuit they have against MPRP. Anything in the neighborhood of $35M would be very welcome news. Throw in the $25M on Hawkeye and they have $60m to get moving towards debt free. I still believe we could see $50+++++ a share in the next two years.
I believe the untold story will be the modular cryogenic plants. One company alone in the Marcellus shale play has 14,000 wells. Economically you cannot build these plants on every well, however I feel that the key here is you can economically put a modular unit on more of them now. This could be a $100B market to be tapped. Yes I did say $100B spread over 20 years. If just 1% of the 14,000 wells one company has rights to, opt for a modular unit, that's 140 of these modular units. Let's say they cost $50M to install, that's $7B in revenues. Where's spandex and spurs?
Sentiment: Strong Buy
Google "China's Move to End IPO Halt Sparks Rally in Finance Stocks".
Here is one piece of it:
The IPO freeze will be lifted following new rules that pave the way for a switch to a U.S.-style registration system and letting investor demand determine pricing, underscoring Communist Party leaders’ pledge to allow markets to play a “decisive” role in allocating resources. China, the world’s largest IPO market in 2010, hasn’t had a new listing since October 2012 amid a crackdown on fraud and misconduct.
“Resuming IPOs will be a big boost to brokerages’ investment banking business,” Zhang Yanbing, a Shanghai-based analyst at Zheshang Securities Co., said by telephone. “Some investors believe that China’s stock market will enter a bull market soon.”
Smaller companies led declines today on concern new stock sales will divert funds from existing equities. The ChiNext Index of companies with a median market value of $1 billion tumbled 8.3 percent today, its biggest retreat since it was created in June 2010. The gauge has surged 76 percent this year.
I'll bite. How does this have anything to do with BMGP? Some of us are not as smart as you. Maybe you could write a book...call it RTO's for dummies. Here's an outline of Chapters:
Find the next RTO:
Help promote the RTO story:
What you do when they do a 1 for 200 reverse split:
Jumping on the next RTO:
Getting in bed with the stock promoters:
The previous step needed, to point your finger away from yourself:
Must use multiple id's when pumping and bashing:
Do your DD after you lose money:
Once you lose, take no responsibility:
Attack anyone who doesn't share your views:
Asking for your money back:
Once you take a bath and cannot find another RTO to promote because you're broke:
Post negative info, the art of deception:
When you cannot make others lose like you did, you insult new investors:
No matter how contrived a piece of info is, you try and link it to investment:
When confronted on lies, always point finger like you are the victim:
Growing up is not in the cards:
Waste three years doing DD after you lose money:
Monitoring message boards 24/7:
Poor choice "big boards". Difinitely off the BB. My 85% ownership by insiders is the 60% COC will own and the 25% frost/opk own. I guess that makes it 70% insiders own. (25% of 40%=10%) +60% COC.
Sentiment: Strong Buy
They have two compounds that are at the Lead Optimization Stage. What that means is this:
In the lead optimization stage of drug discovery process researchers must select the leads with the greatest potential to be developed into safe and effective medicines.
During this stage of drug research, one must focus not only on increasing the biological acivity, but also on a number of drug-like parameters, including: permeability, metabolic stability, lipophilicity, solubility, plasma-protein binding, CYP450 interactions, pKa, PK/PD, etc. Preclinical lead optimization technologies must be sufficiently rapid to interface with high-throughput screens without creating a further pipeline bottleneck, be predictive of drug failure, and be highly cost-effective.
Sentiment: Strong Buy